Tirtha Chakraborty
Direttore Tecnico/Scientifico/R&S presso VOR BIOPHARMA INC.
Patrimonio netto: 304 696 $ in data 30/04/2024
Posizioni attive di Tirtha Chakraborty
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VOR BIOPHARMA INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2020 | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Consulente / Consigliere | 24/07/2023 | - |
Storia della carriera di Tirtha Chakraborty
Precedenti posizioni note di Tirtha Chakraborty
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/10/2018 | 01/10/2019 |
| CRISPR THERAPEUTICS AG | Direttore/Membro del Consiglio | 01/01/2015 | 01/10/2018 |
| Corporate Officer/Principal | 01/01/2015 | 01/10/2018 |
Formazione di Tirtha Chakraborty
| Tata Institute of Fundamental Research | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Svizzera | 2 |
| India | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VOR BIOPHARMA INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Aziende private | 1 |
|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Commercial Services |
- Borsa valori
- Insiders
- Tirtha Chakraborty
- Esperienza
